Attention deficit hyperactivity disorder and obsessive-compulsive disorder among former heroin addicts currently in methadone maintenance treatment

Psychopathology

Volumn 45, Issue 5, 2012, Pages 327-333

  Peles, Einat ^a,b   Schreiber, Shaul ^a,b   Sutzman, Agata ^a   Adelson, Miriam ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Attention deficit hyperactivity disorder; Methadone maintenance treatment; Obsessive compulsive disorder; Risk factors; Trauma history

Indexed keywords

METHADONE; NARCOTIC ANTAGONIST;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CROSS-SECTIONAL STUDY; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; MIDDLE AGED; OBSESSIVE COMPULSIVE DISORDER; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CROSS-SECTIONAL STUDIES; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OBSESSIVE-COMPULSIVE DISORDER; OPIATE SUBSTITUTION TREATMENT; QUESTIONNAIRES;

EID: 84865750077     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000336219     Document Type: Article

References (48)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, ed 4, text revision. Washington, American Psychiatric Press, 2000.
2. Biederman J, Petty CR, Evans M, Small J, Faraone SV: How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res 2010; 177: 299-304.
3. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164: 942-948. (Pubitemid 46972911)
4. Rhee SH, Waldman ID: Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies. Psychol Bull 2002; 128: 490-529.
5. Dopheide JA, Pliszka SR: Attention-deficithyperactivity disorder: an update. Pharmacotherapy 2009; 29: 656-679.
6. Barkley RA, Cox D: A review of driving risks and impairments associated with attentiondeficit/ hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res 2007; 38: 113-128. (Pubitemid 46321543)
7. Minkoff NB: ADHD in managed care: an assessment of the burden of illness and proposed initiatives to improve outcomes. Am J Manag Care 2009; 15:S151-S159.
8. Kollins SH: A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders. Curr Med Res Opin 2008; 24: 1345-1357. (Pubitemid 351741566)
9. Schubiner H: Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications. CNS Drugs 2005; 19: 643-655. (Pubitemid 41305982)
10. Wilens TE: Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry 2004; 65: 38-45.
11. Elkins IJ, McGue M, Iacono WG: Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007; 64: 1145-1152. (Pubitemid 47529338)
12. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV: Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics 2009; 124: 71-78.
13. Faraone SV, Wilens TE: Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. J Clin Psychiatry 2007; 68: 15-22. (Pubitemid 47606857)
14. Peterson K, McDonagh MS, Fu R: Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl) 2008; 197: 1-11.
15. Kolpe M, Carlson GA: Influence of attention-deficit/hyperactivity disorder symptoms on methadone treatment outcome. Am J Addict 2007; 16: 46-48. (Pubitemid 46341008)
16. Brooks DJ, Vosburg SK, Evans SM, Levin FR: Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence. J Addict Dis 2006; 25: 15-25. (Pubitemid 44707286)
17. King VL, Brooner RK, Kidorf MS, Stoller KB, Mirsky AF: Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis 1999; 187: 487-495. (Pubitemid 29422603)
18. Carpentier PJ, van Gogh MT, Knapen LJ, Buitelaar JK, De Jong CA: Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res 2011; 17: 10-20.
19. Peles E, Adelson M, Schreiber S; Association of OCD with a history of traumatic events among patients in methadone maintenance treatment. CNS Spectr 2009; 14: 547-554.
20. Peles E, Schreiber S, Adelson M: Pathological gambling and obsessive compulsive disorder among methadone maintenance treatment patients. J Addict Dis 2009; 28: 199-207.
21. Geller DA: Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 2006; 29: 353-370.
22. Carlson C, Papolos D, Pandita RK, Faedda GL, Veit S, Goldberg R, Shprintzen R, Kucherlapati R, Morrow B: Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet 1997; 60: 851-859. (Pubitemid 27146493)
23. Lindsay EA: Chromosomal microdeletions: dissecting del22q11 syndrome. Nat Rev Genet 2001; 2: 858-868. (Pubitemid 33674032)
24. Michaelovsky E, Gothelf D, Korostishevsky M, Frisch A, Burg M, Carmel M, Steinberg T, Inbar D, Apter A, Weizman A: Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS. Int J Neuropsychopharmacol 2008; 11: 351-363. (Pubitemid 351482504)
25. Adelson MO, Hayward R, Bodner G, Bleich A, Gelkopf M, Kreek MJ: Replication of an effective opiate addiction pharmacotherapeutic treatment model: minimal need for modification in a different country. J Maint Addict 2000; 1: 5-13.
26. Peles E, Schreiber S, Adelson M: 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend 2010; 107: 141-148.
27. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE: The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005; 35: 245-256. (Pubitemid 40259916)
28. Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Biederman J, Secnik K: Validity of pilot Adult ADHD Self-Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry 2006; 18: 145-148. (Pubitemid 44576434)
29. Ward MF, Wender PH, Reimherr FW: The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 885-890. (Pubitemid 23156767)
30. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
31. Shalev AY, Sahar T, Abramovitz M: Hebrew version: SCID (DSM-IV): Structured Clinical Interview for Axis I DSM-IV Disorders, SCID-I/P (version 2.0), patient Version. Jerusalem, Department of Psychiatry, Hadassah University Hospital, 1996.
32. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
33. Lorr M, Klett CJ, McNair DM, et al: Inpatient Multidimensional Psychiatric Scale Manual. Palo Alto, Consulting Psychologists Press, 1962.
34. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011. (Pubitemid 19278229)
35. McLellan AT, Luborsky L, O'Brien CP, Barr HL, Evans F: The Addiction Severity Index in three different populations. NIDA Res Monogr 1984; 55: 217-223. (Pubitemid 15024150)
36. Fagerstrom KO: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3: 235-241.
37. Hawks RL: Analytical methodology. NIDA Res Monogr 1986; 73: 30-42.
38. Hosmer DW, Lemeshow S: A goodness-of-fit test for the multiple logistic regression model. Comm Stat 1980;A10: 1043-1069.
39. National Institute for Health and Clinical Excellence: Attention deficit hyperactivity disorder diagnosis and management of ADHD in children, young people and adults. NICE Clinical Guideline 72. London, National Institute for Health and Clinical Excellence, 2009.
40. Buitelaar JK, Rothenberger A: Foreword-ADHD in the scientific and political context. Eur Child Adolesc Psychiatry 2004; 13(suppl 1):I1-I6.
41. Nigg JT, Tannock R, Rohde LA: What is to be the fate of ADHD subtypes? An introduction to the special section on research on the ADHD subtypes and implications for the DSM-V. J Clin Child Adolesc Psychol 2010; 39: 723-725.
42. Seidman LJ, Doyle A, Fried R, Valera E, Crum K, Matthews L: Neuropsychological function in adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 27: 261-282. (Pubitemid 38452767)
43. Huss M, Hölling H, Kurth BM, Schlack R: How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). Eur Child Adolesc Psychiatry 2008; 1: 52-58.
44. Peles E, Adelson M: Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic. J Addict Dis 2006; 25: 39-45. (Pubitemid 44157067)
45. Peles E, Schreiber S, Adelson M: Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 2006; 82: 211-217.
46. Schiff M, Levit S, Moreno RC: Retention and illicit drug use among methadone patients in Israel: a gender comparison. Addict Behav 2007; 32: 2108-2119. (Pubitemid 47198946)
47. Masi G, Millepiedi S, Perugi G, Pfanner C, Berloffa S, Pari C, Mucci M, Akiskal HS: A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder. Psychopathology 2010; 43: 69-78.
48. Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD: Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry 2007; 61: 1320-1328. (Pubitemid 46855768)